153 related articles for article (PubMed ID: 34983483)
1. Adjusted association between type 2 immunity and low risk thyroid nodules: a retrospective cohort study.
Wang S; Wang X; Hua X; Jiang S; Xie Y; Liu H
BMC Endocr Disord; 2022 Jan; 22(1):2. PubMed ID: 34983483
[TBL] [Abstract][Full Text] [Related]
2. Thyroglobulin antibody is associated with increased cancer risk in thyroid nodules.
Kim ES; Lim DJ; Baek KH; Lee JM; Kim MK; Kwon HS; Song KH; Kang MI; Cha BY; Lee KW; Son HY
Thyroid; 2010 Aug; 20(8):885-91. PubMed ID: 20465529
[TBL] [Abstract][Full Text] [Related]
3. The Impact of Metabolic Syndrome on Increased Risk of Thyroid Nodules and Size.
Bener A; Özdenkaya Y; Barışık CC; Öztürk M
Health Serv Res Manag Epidemiol; 2018; 5():2333392818775517. PubMed ID: 35146073
[TBL] [Abstract][Full Text] [Related]
4. The Relationship of TPOAb and TGAb with Risk of Thyroid Nodules: A Large Epidemiological Study.
Xu W; Huo L; Chen Z; Huang Y; Jin X; Deng J; Zhu S; Yu Y
Int J Environ Res Public Health; 2017 Jul; 14(7):. PubMed ID: 28678169
[No Abstract] [Full Text] [Related]
5. Epidemiological characteristics of thyroid nodules and risk factors for malignant nodules: a retrospective study from 6,304 surgical cases.
Huan Q; Wang K; Lou F; Zhang L; Huang Q; Han Y; Sun H; Zhu L; Lin P; Song J; Liu F; Wang Q; Hou W
Chin Med J (Engl); 2014; 127(12):2286-92. PubMed ID: 24931243
[TBL] [Abstract][Full Text] [Related]
6. Association of Hashimoto's thyroiditis with thyroid cancer.
Azizi G; Keller JM; Lewis M; Piper K; Puett D; Rivenbark KM; Malchoff CD
Endocr Relat Cancer; 2014; 21(6):845-52. PubMed ID: 25217233
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of thyroid nodules and their associated clinical parameters: a large-scale, multicenter-based health checkup study.
Moon JH; Hyun MK; Lee JY; Shim JI; Kim TH; Choi HS; Ahn HY; Kim KW; Park DJ; Park YJ; Yi KH
Korean J Intern Med; 2018 Jul; 33(4):753-762. PubMed ID: 28859466
[TBL] [Abstract][Full Text] [Related]
8. A predictive model of thyroid malignancy using clinical, biochemical and sonographic parameters for patients in a multi-center setting.
Liu J; Zheng D; Li Q; Tang X; Luo Z; Yuan Z; Gao L; Zhao J
BMC Endocr Disord; 2018 Mar; 18(1):17. PubMed ID: 29514621
[TBL] [Abstract][Full Text] [Related]
9. Association Between Thyroid Nodules and Volume and Metabolic Syndrome in an Iodine-Adequate Area: A Large Community-Based Population Study.
Su Y; Zhang YL; Zhao M; Zhang HQ; Zhang X; Guan QB; Yu CX; Shao SS; Xu J
Metab Syndr Relat Disord; 2019 May; 17(4):217-222. PubMed ID: 30741593
[No Abstract] [Full Text] [Related]
10. Bisphenol A exposure and risk of thyroid nodules in Chinese women: A case-control study.
Li L; Ying Y; Zhang C; Wang W; Li Y; Feng Y; Liang J; Song H; Wang Y
Environ Int; 2019 May; 126():321-328. PubMed ID: 30825751
[TBL] [Abstract][Full Text] [Related]
11. Positive Thyroid Peroxidase Antibody and Thyroglobulin Antibody are Associated With Better Clinicopathologic Features of Papillary Thyroid Cancer.
Li L; Shan T; Sun X; Lv B; Chen B; Liu N; Zhang B; Hu S; Zeng Q; Turner AG; Sheng L
Endocr Pract; 2021 Apr; 27(4):306-311. PubMed ID: 33645517
[TBL] [Abstract][Full Text] [Related]
12. [Detection rate of thyroid nodules in routine health check-up and its influencing factors: a 10-year survey of 309 576 cases].
Lai X; Ouyang P; Zhu H; An S; Xia L; Yao Y; Zhang H; Li Z; Deng K
Nan Fang Yi Ke Da Xue Xue Bao; 2020 Feb; 40(2):268-273. PubMed ID: 32376525
[TBL] [Abstract][Full Text] [Related]
13. Relationship between metabolic syndrome and thyroid nodules in healthy Koreans.
Shin J; Kim MH; Yoon KH; Kang MI; Cha BY; Lim DJ
Korean J Intern Med; 2016 Jan; 31(1):98-105. PubMed ID: 26767863
[TBL] [Abstract][Full Text] [Related]
14. The association of uric acid with the development of thyroid nodules: a retrospective cohort study.
Huang Y; Li Z; Yang K; Zhang L; Wei C; Yang P; Xu W
BMC Endocr Disord; 2022 Aug; 22(1):197. PubMed ID: 35941598
[TBL] [Abstract][Full Text] [Related]
15. Metabolic syndrome and its components are associated with increased thyroid volume and nodule prevalence in a mild-to-moderate iodine-deficient area.
Ayturk S; Gursoy A; Kut A; Anil C; Nar A; Tutuncu NB
Eur J Endocrinol; 2009 Oct; 161(4):599-605. PubMed ID: 19633072
[TBL] [Abstract][Full Text] [Related]
16. HIGHER SERUM OSTEOPROTEGERIN LEVELS IN SUBJECTS WITH THYROID NODULES.
Zhang H; Yang Z; Zhang W; Niu Y; Li X; Qin L; Su Q
Endocr Pract; 2016 Apr; 22(4):412-9. PubMed ID: 26595513
[TBL] [Abstract][Full Text] [Related]
17. The Presence of Serum TgAb Suggests Lower Risks for Glucose and Lipid Metabolic Disorders in Euthyroid General Population From a National Survey.
Zhang J; Gao Y; Li Y; Teng D; Xue Y; Yan L; Yang J; Yang L; Yao Y; Ba J; Chen B; Du J; He L; Lai X; Teng X; Shi X; Li Y; Chi H; Liao E; Liu C; Liu L; Qin G; Qin Y; Quan H; Shi B; Sun H; Tang X; Tong N; Wang G; Zhang JA; Wang Y; Ye Z; Zhang Q; Zhang L; Zhu J; Zhu M; Teng W; Shan Z; Li J
Front Endocrinol (Lausanne); 2020; 11():139. PubMed ID: 32256451
[No Abstract] [Full Text] [Related]
18. The prevalence of thyroid nodules in northwest China and its correlation with metabolic parameters and uric acid.
Liu Y; Lin Z; Sheng C; Zhu Y; Huang Y; Zhong N; Jia Z; Qu S
Oncotarget; 2017 Jun; 8(25):41555-41562. PubMed ID: 28107199
[TBL] [Abstract][Full Text] [Related]
19. Both thyroid autoimmunity and increased serum TSH are independent risk factors for malignancy in patients with thyroid nodules.
Boi F; Minerba L; Lai ML; Marziani B; Figus B; Spanu F; Borghero A; Mariotti S
J Endocrinol Invest; 2013 May; 36(5):313-20. PubMed ID: 22931861
[TBL] [Abstract][Full Text] [Related]
20. High prevalence of suspicious cytology in thyroid nodules associated with positive thyroid autoantibodies.
Boi F; Lai ML; Marziani B; Minerba L; Faa G; Mariotti S
Eur J Endocrinol; 2005 Nov; 153(5):637-42. PubMed ID: 16260421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
